# Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes

> **NCT01023165** · PHASE3 · UNKNOWN · sponsor: **Global Infusion and Aspiration Systems, LLC** · enrollment: 2000 (estimated)

## Conditions studied

- Diabetes Mellitus
- Metabolic Integrity

## Interventions

- **PROCEDURE:** Humulin, Humalog, Novolog

## Key facts

- **NCT ID:** NCT01023165
- **Lead sponsor:** Global Infusion and Aspiration Systems, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2014-11
- **Final completion:** 2015-11
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2011-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01023165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01023165, "Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01023165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*